This is not the most recent version of the article. View current version (18 APR 2012)

Intervention Protocol

Neurokinin-1 receptor antagonists for prevention of chemotherapy-related nausea and vomiting in adults

  1. Ivo W Tremont-Lukats1,*,
  2. Eduardo Bruera2,
  3. Jesús González-Barboteo3

Editorial Group: Cochrane Pain, Palliative and Supportive Care Group

Published Online: 17 OCT 2007

DOI: 10.1002/14651858.CD006844

How to Cite

Tremont-Lukats IW, Bruera E, González-Barboteo J. Neurokinin-1 receptor antagonists for prevention of chemotherapy-related nausea and vomiting in adults (Protocol). Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD006844. DOI: 10.1002/14651858.CD006844.

Author Information

  1. 1

    Louisiana State University, Neurology, Marrero, Louisiana, USA

  2. 2

    University of Texas M. D. Anderson Cancer Center, Palliative care and Rehab, Houston, Texas, USA

  3. 3

    Hospital Vírgen de La Salud, Unidad de Cuidados Paliativos, Toledo, Spain

*Ivo W Tremont-Lukats, Neurology, Louisiana State University, 1111 Medical Center Boulevard, Suite S-750, Marrero, Louisiana, 77072, USA. itremont@earthlink.net.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 17 OCT 2007

SEARCH

This is not the most recent version of the article. View current version (18 APR 2012)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

  • To assess the effectiveness of NK1 receptor antagonists in controlling acute and delayed nausea and vomiting in participants on moderate and highly emetogenic chemotherapy.
  • To determine the adverse events associated with NK1 receptor antagonists in participants receiving these drugs.
  • To assess the effect that NK1 receptor antagonists have had on the quality of life of participants treated with moderate and highly emetogenic chemotherapy.